Over 10 years experience of Traceability Solutions

New Drug Development Strategies Needed for Alzheimer’s Treatments
24 May

By pharmatrax

Category: Technoloy

New Drug Development Strategies Needed for Alzheimer’s Treatments No Comments

New Drug Development Strategies Needed for Alzheimer’s Treatments

Selecting a single CRO partner that can take CNS compounds from functional screening in vitro through in vivo and beyond Today, 50 million people worldwide…

Read More
FDA highlights manufacturing quality efforts after recalls regulatory criticism
23 May

By pharmatrax

Category: News

FDA highlights manufacturing quality efforts after recalls, regulatory criticism No Comments

FDA highlights manufacturing quality efforts after recalls, regulatory criticism

Dive Brief: The Food and Drug Administration issued its annual report Monday on the state of pharmaceutical quality, highlighting its inspection efforts and offering geographic and industry…

Read More
Novartis
22 May

By pharmatrax

Category: News

Novartis could settle for $1B as part of federal kickback lawsuit: report No Comments

Novartis could settle for $1B as part of federal kickback lawsuit: report

Six years after federal prosecutors first targeted Novartis for an alleged kickback scheme involving $10,000 dinners and fishing trips for doctors, signs pointed to the…

Read More
Torrent Losartan potassium HCT
21 May

By pharmatrax

Category: News

FDA finds testing issues at Torrent plant No Comments

FDA finds testing issues at Torrent plant

A year after Torrent Pharmaceuticals first began recalling tainted losartan products manufactured at its Indrad plant, the FDA paid a visit. It found a plant…

Read More
Endo subsidiary issues recall after glass contamination wrbm large
20 May

By pharmatrax

Category: News

Par recalls product after glass particulate contamination No Comments

Par recalls product after glass particulate contamination

Par Pharmaceutical initiates a recall of mycophenolate mofetil injection, after a vial containing a glass fragment was discovered during reconstitution. The voluntary recall involves only…

Read More
Manufacturing Revolution In Medicine
16 May

By pharmatrax

Category: Technoloy

Industry 4.0 in the Pharma Industry No Comments

Industry 4.0 in the Pharma Industry

From sensors and software to data-based services throughout production, Industry 4.0 solutions are opening new potentials in terms of transparency, quality, safety and efficiency. In…

Read More
FDA & Data Integrity
15 May

By pharmatrax

Category: Technoloy

FDA & Data Integrity No Comments

FDA & Data Integrity

On December 13, 2018 the U.S. Food and Drug Administration (FDA) released the final version of its guidance titled, “Data Integrity and Compliance with Drug…

Read More
Manufacturing Revolution In Medicine
14 May

By pharmatrax

Category: Technoloy

The Manufacturing Revolution In Medicine No Comments

The Manufacturing Revolution In Medicine

Real-time data insights help both pharma companies and contract manufacturers meet regulatory requirements while ensuring high production standards. Pharmaceutical companies are locked in a perpetual…

Read More
Big Pharma executives
13 May

By pharmatrax

Category: News

Big Pharma executives convicted of criminal racketeering with opioid sales No Comments

Big Pharma executives convicted of criminal racketeering with opioid sales

Even as more felony charges may follow in drug epidemic, sleep med warning suggests pill popping stays too popular Five top executives at a major…

Read More
Yet Another BP Drug Recalled—Recent Study
11 May

By pharmatrax

Category: News

Yet Another BP Drug Recalled—Recent Study No Comments

Yet Another BP Drug Recalled—Recent Study

Teva Pharmaceuticals, on Friday, announced it is recalling its blood pressure medication, Losartan Potassium USP. All 35 lots of the drug, which includes 100 mg…

Read More